Cannabis M&A Diligence — What Buyers Miss

The Regulatory, Tax, and License Risk Hidden in Every Cannabis Deal

Topic Summary

Cannabis M&A transactions carry layers of hidden risk that standard corporate diligence frameworks miss: license transferability restrictions, regulatory approval timelines that can kill deals mid-close, 280E tax exposure that rewrites the cap table, and state-specific change-of-control rules that vary wildly. Robert Hoban draws on 20+ years of cannabis M&A deal experience to give buyers, sellers, and their counsel a practical diligence checklist they can use immediately.

Session Outline

I. The Cannabis M&A Market (2024–2026)

›Deal volume, structure trends (stock vs. asset vs. hybrid), and valuation multiples
›Why cannabis deals fail: top 5 post-LOI killers

II. License Diligence

›Change-of-control provisions by state: which states require pre-approval
›License transferability: restrictions in CA, CO, IL, NJ, NY, and FL
›Regulatory timelines: how long do state approvals take and who bears delay risk?
›Multi-license diligence: vertical integration and the compounding risk

III. Tax Diligence

›§280E exposure analysis as a deal condition
›Successor liability for seller's unpaid cannabis taxes
›§471(c) election status: what to look for in the target's returns
›Structuring for tax efficiency: asset purchase vs. stock purchase in cannabis

IV. Regulatory Compliance Diligence

›Seed-to-sale tracking: METRC audit trail requirements
›Social equity conditions attached to licenses
›Prior enforcement actions and their transferability
›Advertising and packaging compliance backlogs

V. Contract and IP Diligence

›Brand licensing agreements that don't survive a change of control
›Vendor contracts with cannabis-specific termination clauses
›Trademark registration status: USPTO vs. state-level protection

VI. Deal Structuring to Mitigate Diligence Risk

›Escrow and holdback mechanics
›Regulatory approval contingencies
›Representations and warranties insurance in cannabis transactions

VII. Q&A

Suggested Formats

Keynote (45 min)Workshop (2 hr)Panel (60 min)

Best for These Audiences

In-House CounselCannabis OperatorsInvestors

Book this topic

Request “Cannabis M&A Diligence — What Buyers Miss”

Submit a booking inquiry and our team will follow up within 2–3 business days with availability, fee details, and logistics.

Submit a Booking Inquiry